CDIO logo

CARDIO DIAGNOSTICS HOLDINGS

CDIONASDAQ
πŸ† #5017 by market capUS Equity
β€”β€”
Quote unavailable
πŸ””
Track CDIO
Get earnings, price moves & breaking news on Telegram
Track
24hβ€”
7dβ€”
14dβ€”
30dβ€”
ytdβ€”
1yβ€”
🏦Market Cap
$5M
Small Cap
πŸ“ˆRevenue Growth (YoY)
-25.9%
Declining
πŸ“ŠGross Margin
β€”
πŸ’΅FCF Margin
β€”
βš–οΈP/S Ratio
347.9x
Expensive
Otter Score
β€”
Insufficient data
No chart data available for CDIO.

Trading Snapshot

Day Range
β€”
52-Week Range
$0.97 – $7.91
Volume (shares)
β€”
Avg Volume (shares)
β€”
Shares Outstanding
3.0M
Next Earnings
β€”

Fundamentals Snapshot

Annual Revenue
β€”
Last Q Revenue
β€”
P/E Ratio
β€”
P/S Ratio
347.9x
EPS (TTM)
$-2.92
Dividend Yield
β€”
Dilution (1yr)
βˆ’96.0%
CDIO logo

CARDIO DIAGNOSTICS HOLDINGS

CDIO
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$15Kβ–Ό βˆ’57.5% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
100.0%β–² +0.0% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
βˆ’$6Mβ–Ό βˆ’22.5% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
βˆ’$6Mβ–² +9.6% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
1.8Mβ–Ό βˆ’96.0% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
$4Mβ–Ό βˆ’$2M YoY
StockOtter Β· stockotter.space

About CARDIO DIAGNOSTICS HOLDINGS

Cardio Diagnostics Holdings, Inc. specializes in creating and bringing to market advanced clinical diagnostic tools that leverage epigenetic insights to address cardiovascular disease. Among their key offerings is Epi+Gen CHD, a test designed to assess an individual's three-year risk for developing symptomatic coronary heart disease. This company, headquartered in Chicago, Illinois, was established in 2017.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)

Insufficient data for all five components.

πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Insufficient data
β€”/100
Analyst data unavailable.

Latest News & Updates

News unavailable.